Intratumoral Lymphatic Vessel Density in Vulvar Squamous Cell Carcinomas: A Possible Association With Favorable Prognosis
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
BACCHI, Carlos E.
GOES, Joao Carlos Sampaio
CALIL, Marcelo Alvarenga
Citação
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, v.31, n.1, p.8-14, 2012
Resumo
Lymphatic vessels serve as major routes for regional dissemination, and therefore, lymph node status is a key indicator of prognosis. To predict lymph node metastasis, tumor lymphatic density and lymphangiogenesis-related molecules have been studied in various tumor types. To our knowledge, no previous studies have evaluated the role of intratumoral lymphatic vessel density (LVD) in the behavior of vulvar carcinomas. The aim of this study was to analyze intratumoral LVD in relation to patient survival and well-characterized prognostic factors for cancer. Thirty-five patients with vulvar squamous cell carcinoma underwent vulvectomy and dissection of regional lymph nodes. Clinical records were reviewed, in addition to histological grade, peritumoral lymphatic invasion, and depth of infiltration for each case. Tissue microarray paraffin blocks were created, and lymphatic vessels were detected using immunohistochemical staining of podoplanin (D2-40 antibody). Intratumoral LVD was quantified by counting the number of stained vessels. Higher values for intratumoral LVD were associated with low-grade and low-stage tumors, and with tumors without lymphatic invasion and reduced stromal infiltration. In a univariate analysis, high intratumoral LVD was associated with a higher rate of overall survival and a lower rate of lymph node metastasis. Our results suggest that increased intratumoral LVD is associated with favorable prognosis in vulvar squamous carcinomas.
Palavras-chave
Vulvar cancer, Lymphangiogenesis, Prognostic factors, Lymphatic vessels
Referências
- Al-Rawi MAA, 2011, FRONT BIOSCI-LANDMRK, V16, P723, DOI 10.2741/3715
- Birner P, 2001, INT J CANCER, V95, P29, DOI 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO;2-W
- Braun M, 2009, ONKOLOGIE, V32, P732, DOI 10.1159/000252795
- Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693
- Cheng X, 2009, INT J GYNECOL CANCER, V19, P158, DOI 10.1111/IGC.0b013e3181996a78
- Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012
- Gaarenstroom KN, 2003, INT J GYNECOL CANCER, V13, P522, DOI 10.1046/j.1525-1438.2003.13304.x
- Hall FT, 2003, ARCH OTOLARYNGOL, V129, P716, DOI 10.1001/archotol.129.7.716
- Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x
- Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
- Kawamura L, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-89
- Matsumoto K, 2007, DIS COLON RECTUM, V50, P308, DOI 10.1007/s10350-006-0792-y
- Maula SM, 2003, CANCER RES, V63, P1920
- Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284
- Nakamura Y, 2006, J CLIN PATHOL, V59, P77, DOI 10.1136/jcp.2005.028779
- Nicoletto MO, 2010, ANTICANCER RES, V30, P2311
- Oonk MHM, 2006, INT J GYNECOL CANCER, V16, P963, DOI 10.1111/j.1525-1438.2006.00387.x
- Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.2005.CCR-05-1077
- Saad RS, 2010, INT J GYNECOL PATHOL, V29, P386, DOI 10.1097/PGP.0b013e3181c3cd47
- Sotiropoulou N, 2010, PATHOLOGY, V42, P629, DOI 10.3109/00313025.2010.522174
- Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092
- Suzuki H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-287
- Tavassoli FA, 2003, PATHOLOGY GENETICS T
- van der Avoort IA, 2010, AM J OBSTET GYNECOL, V203
- Van der Auwera I, 2006, BRIT J CANCER, V95, P1611, DOI 10.1038/sj.bjc.6603445
- van der Avoort IAM, 2006, INT J GYNECOL PATHOL, V25, P22, DOI 10.1097/01.pgp.0000177646.38266.6a
- Wang XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-299
- Zaganelli Fabricia L, 2010, Int J Gynecol Cancer, V20, P1225, DOI 10.1111/IGC.0b013e3181ead337
- Zhang SQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-64